Adverse events after triazolam substitution

I Hindmarch et al. Lancet. 1993.

. 1993 Jan 2;341(8836):55.

doi: 10.1016/0140-6736(93)92532-x.

No abstract available

Comment in

Triazolam and disinhibition.
Rothschild AJ, Bessette MP, Carter-Campbell J, Murray M. Rothschild AJ, et al. Lancet. 1993 Jan 16;341(8838):186. doi: 10.1016/0140-6736(93)90056-m. Lancet. 1993. PMID: 8093796 No abstract available.
Adverse events after triazolam substitution.
Hawley CJ, Walker M, Roberts A. Hawley CJ, et al. Lancet. 1993 Feb 27;341(8844):567. Lancet. 1993. PMID: 8094812 No abstract available.
Adverse events after triazolam substitution.
Vela-Bueno A. Vela-Bueno A. Lancet. 1993 Feb 27;341(8844):567. Lancet. 1993. PMID: 8094813 No abstract available.
Adverse events after triazolam substitution.
Kales A, Bixler EO, Vgontzas AN. Kales A, et al. Lancet. 1993 Feb 27;341(8844):567-8. Lancet. 1993. PMID: 8094814 No abstract available.